NUCLEU DE CERCETARE CHIRURGIE CARDIOVASCULARA

STRUCTURA DE CERCETARE STIINTIFICA

Nr.crt.

Nume si prenume

Functia

Specialitatea

Observatii

1.

Condu Silvia

cercetator stiintific – medic specialist

Chirurgie vasculara

LABORATOR DE CERCETARE CARDIOLOGIE

STRUCTURA DE CERCETARE STIINTIFICA

Nr.crt.

Nume si prenume

Functia

Specialitatea

Observatii

1.

CorlanAlexandru

cercetator stiintific – medic specialist

Cardiologie

2.

Bicescu Gabriela

cercetetorstiintific HI – medic primar

Cardiologie

3.

Mincu Raluca Ileana

cercetator stiintific – medic specialist

Cardiologie

4.

VasileNora

cercetator stiintific – medic specialist

Cardiologie

5.

Magda Lucia Stefania

cercetator stiintific – medic specialist

Cardiologie

6.

Dragoi Antunes Guerla Ruxandra

cercetator stiintific – medic specialist

Cardiologie

Dr. Alexandru Corlan – cercetator stiintific – medic specialist

◊ „Modernization at international standards of BCDM: Base of the invasive exploration and computed modulation of arrhythmic mechanisms” CARDIORITMCONTROL, Grant of Ministry of Research and Education 2008-2010”.

◊ „Modelarea matematica a activitatii electrice a neuronilor si cardiomiocitelor izolate si in tesut cu aplicatii in predictia aritmiilor si a raspunsului la antiaritmice ” – PROIECT PNCDII – 061-010/2007.

◊ „Dezvoltarea unor centre cardiologice prin screening al populatiei cu factori de risc ai disfunctiei cardiac ” – PROIECT PNCDII – 13/2005.

Dr. Gabriela Bicescu – cercetetor stiintific HI – medic primar

◊ ”Assessment of SIMVASTATINE effect on systemic inflammation, on the subclinical cardiac involvement and on the early atherosclerosis in rheumatoid arthritis (CESIA)” – Grant of Ministry of Research and Education (2006).

◊ ”Cardiologic research base of acute cardiac failure.” Grant of Ministry of Research and Education. 2007- 2009.

Dr. Nora Vasile – cercetator stiintific – medic specialist

◊ ”Assessment of SIMVASTATINE effect on systemic inflammation, on the subclinical cardiac involvement and on the early atherosclerosis in rheumatoid arthritis (CESIA)” – Grant of Ministry of Research and Education (2006).

◊ ”Cardiologic research base of acute cardiac failure” Grant of Ministry of Research and Education 2007-2009.

Dr. Maria Florescu

◊ ”Assessment of SIMVASTATINE effect on systemic inflammation, on the subclinical cardiac involvement and on the early atherosclerosis in rheumatoid arthritis (CESIA)” – Grant of Ministry of Research and Education (2006).

◊ ”Cardiologic research base of acute cardiac failure.” Grant of Ministry of Research and Education. 2007-2009

◊ ”Echocardiographic assessment of acute pulmonary edema” Grant of Ministry of Research and Education 2007-2009.

◊ ”Modernization  at  international  standards  of  BCUM:  Base  of  the  invasive  exploration  and computed modulation of arrhythmic mechanisms” CARDIORITMCONTROL, Grant of Ministry of Research and Education  2008-2010.

◊ Application to the European Projects FP7: “Personalized Cardiovascular Disease Management Through  Multiparametric  Monitoring and  Modeling  of Patients with  Implanted Cardiovascular Electronic Devices”, march 2009

◊ Researcher at the project IDEI 112/27 mt 2011 “DIAGNOSIS AND PREDICTION OF SUBCLINICAL CARDIAC DYSFUNCTION INDUCED BY THERAPY WITH TAXANES IN PATIENTS WITH BREAST CANCER”

Dr. Stefania Magda – cercetator stiintific – medic specialist

◊ ”Assessment of SIMVASTATINE effect on systemic inflammation on the subclinical cardiac involvement and on the early atherosclerosis in rheumatoid arthritis (CESIA)” – Grant of Ministry of Research and Education (2006).

◊ ”Cardiologic research base of acute cardiac failure.” Grant of Ministry of Research and Education; 2007-2009.

◊ Application to the European Projects FP7: “Personalized Cardiovascular Disease Management Through Multiparametric Monitoring and Modeling of Patients with Implanted Cardiovascular Electronic Devices”, march 2009.

◊ Researcher at the project IDEI 112/27 oct 2011 “DIAGNOSIS AND PREDICTION OF SUBCLINICAL CARDIAC DYSFUNCTION INDUCED BY THERAPY WITH TAXANES IN PATIENTS WITH BREAST CANCER”